BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11000698)

  • 1. [Alcohol dependence treatment with naltrexone: safety assessment. Observation study group of alcoholic dependence].
    Ochoa Mangado E; Arias Horcajadas F; Torres Hernández MA
    Actas Esp Psiquiatr; 2000; 28(3):161-8. PubMed ID: 11000698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Brown ES; Beard L; Dobbs L; Rush AJ
    Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone in the treatment of alcohol dependence: a Canadian trial.
    Romach MK; Sellers EM; Somer GR; Landry M; Cunningham GM; Jovey RD; McKay C; Boislard J; Mercier C; Pépin JM; Perreault J; Lemire E; Baker RP; Campbell W; Ryan D
    Can J Clin Pharmacol; 2002; 9(3):130-6. PubMed ID: 12422250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of naltrexone in the treatment of alcohol dependence disorder in women].
    Ponce G; Sánchez-García J; Rubio G; Rodríguez-Jiménez R; Jiménez-Arriero MA; Palomo T
    Actas Esp Psiquiatr; 2005; 33(1):13-8. PubMed ID: 15704026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Naltrexone use in the treatment of alcoholism in Spain].
    Rubio Valladolid G; Espí Martínez F; Sanchís Fortea M; Bravo García De Laguna JL
    Rev Clin Esp; 2002 Aug; 202(8):435-9. PubMed ID: 12199993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?
    Rubio G; Ponce G; Rodriguez-Jiménez R; Jiménez-Arriero MA; Hoenicka J; Palomo T
    Alcohol Alcohol; 2005; 40(3):227-33. PubMed ID: 15797885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.
    O'Malley SS; Rounsaville BJ; Farren C; Namkoong K; Wu R; Robinson J; O'Connor PG
    Arch Intern Med; 2003 Jul; 163(14):1695-704. PubMed ID: 12885685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study.
    Yoon G; Kim SW; Thuras P; Westermeyer J
    Hum Psychopharmacol; 2011 Mar; 26(2):125-32. PubMed ID: 21437991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence.
    De Sousa A; De Sousa A
    Alcohol Alcohol; 2004; 39(6):528-31. PubMed ID: 15525790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alcohol consumption in opioid-dependence patients in treatment with naltrexone].
    Ochoa Mangado E; Arias Horcajadas F
    Actas Esp Psiquiatr; 2000; 28(4):239-49. PubMed ID: 11116795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.
    Galloway GP; Koch M; Cello R; Smith DE
    BMC Psychiatry; 2005 Apr; 5():18. PubMed ID: 15804355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using naltrexone in inpatient alcoholism treatment.
    Knox PC; Donovan DM
    J Psychoactive Drugs; 1999; 31(4):373-88. PubMed ID: 10681104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.